|
|
|
|
SR0546 |
|
LRB095 18859 DRJ 44993 r |
|
|
| 1 |
| SENATE RESOLUTION
|
| 2 |
| WHEREAS, Methicillin-resistant Staphylococcus aureus |
| 3 |
| (MRSA)
is a type of staphylococcal infection that is resistant |
| 4 |
| to
treatment with the usual antibiotics; and
|
| 5 |
| WHEREAS, The proportion of infections which are |
| 6 |
| antimicrobial
resistant in the United States has grown from 2% |
| 7 |
| in 1974 to 63%
in 2004; and
|
| 8 |
| WHEREAS, MRSA occurs most frequently among individuals in
|
| 9 |
| hospitals and health care facilities, particularly the |
| 10 |
| elderly,
those undergoing dialysis, and those with surgical |
| 11 |
| wounds; and
|
| 12 |
| WHEREAS, Individuals infected with MRSA are most likely to
|
| 13 |
| have longer and more expensive hospital stays; and
|
| 14 |
| WHEREAS, Clusters of MRSA have been reported since 2000 |
| 15 |
| among
competitive sports teams, where it is transmitted through
|
| 16 |
| personal contact, sharing towels or equipment, and sharing |
| 17 |
| locker
facilities; and
|
| 18 |
| WHEREAS, Anyone, not just an infected patient, can be a
|
| 19 |
| vehicle for the transmission of MRSA through skin-to-skin
|
| 20 |
| contact; and
|